ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	16 February 2021
Main ID:	NCT02221141
Date of registration:	18/08/2014
Prospective Registration:	No
Primary sponsor:	Laurence Gabriel
Public title:	Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
Scientific title:
Date of first enrolment:	December 2013
Target sample size:	300
Recruitment status:	Recruiting
URL:	https://clinicaltrials.gov/show/NCT02221141
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Belgium

Contacts

Name:	Laurence Gabriel
Address:
Telephone:	+32 81 42 21 11
Email:	laurence.gabriel@uclouvain.be
Affiliation:

Key inclusion & exclusion criteria

Inclusion Criteria:

- unexplained left ventricular hypertrophy

Exclusion Criteria:

- isolated septal hypertrophy

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Left Ventricular Hypertrophy

Intervention(s)

Primary Outcome(s)

Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation [Time Frame: 1 day]

Secondary Outcome(s)

Secondary ID(s)

Fabry Disease Cardioscreening

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.